Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion type Assertion NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_head.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_provenance.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion evidence source_evidence_literature NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_provenance.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion SIO_000772 25490527 NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_provenance.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion wasDerivedFrom befree-2016 NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_provenance.
- NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_assertion wasGeneratedBy ECO_0000203 NP1246458.RAe0F-a6lYwyuZxN1dRxNafcR4Nc7X33BQHsOTZWxE5Us130_provenance.